$SFLM DD - Updated December 11,

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
414
$SFLM DD - Updated December 11, 2022

Backstory

- From October 2020 to November 2022, SFLMaven Corp - ticker $SFLM [formerly $SKDI to March 2021] - comprised only the wholly owned subsidiary SFLMaven of Florida, LLC - a Top Rated eBay seller of jewelry in business for 19+ years.

- Despite SFLMaven of Florida, LLC increasing gross revenue by 35% in 2021 over 2020 - and being on track for a further 15%>20% increase in 2022, it was still operating at a net loss in 2022 Q3 after taking into account large past adjustments for eBay seller's fees in earlier backdated periods.

- In Summer 2022, $SFLM opened a Metaverse store, started to create a collection of NFT items for sale and filed a provisional patent for its "HoloGlow" technology - a ground-breaking technology that allows NFT’s to have a graphical interface that tells others the NFT has significant value [source: PR dated July 26, 2022].

"New" SFLMaven Corp [$SFLM] - Effective November 15, 2022 Onwards

On November 15, 2022, it was PR'ed that:

- Chad MacKay had been appointed as Chairman and CEO of SFLMaven Corp [replacing Joe Ladin].

- He will oversee the launch of the Company’s new business plan that focuses on acquisitions or technology licensing opportunities.

- The Company will focus on identifying companies and/or technologies that could be impactful in their respective industries.

- Chad MacKay is the co-founder and managing partner of Loyal Companies, a private equity firm focusing on mergers and acquisitions.

- The Company’s previous Chairman and CEO, Joseph Ladin, resigned as Chairman and CEO as part of these changes.

- SFLMaven Corp has decided to divest of its operating subsidiary, SFLMaven of Florida, LLC.

- It has not yet been stated whether the Metaverse store and/or the patent pending "HoloGlow" technology is included in the divestiture transaction.

$SFLM CEO - Chad MacKay

- Prior to joining Loyal Companies, Chad MacKay was founder and managing partner of Kai Data Companies.

- He has been actively involved as a director with other companies and organizations. Among the boards on which he serves currently and in the past are: Loyal Companies, Revvu, Cumulus, Cumulus Advanced Technologies, Kai Data, Vulcan7, Espresso Agent, Team Leads, Bear River Management Group, Kai Insurance, Synergy Holdings, RAD, Loyal Technologies, Trustee for Chase N' Heaven and Brother's Keeper.

- In the November 15, 2022 PR he stated:

- “I am very excited to become a part of SFLMaven Corp as the Company’s Chairman and CEO."

- "I have been in private equity for the past 15 years and have done a lot of exciting deals."

- "Our team has built an impressive deal flow of prospects that could be acquired or technology that could be licensed by SFLM.”

- “Our goal will be to add acquisitions and/or licensing agreements to technologies that we believe will be accretive to the Company and our Shareholders. For example, we are working with one credible University on some amazing technologies in the lithium mining industry that could be really important to the future of electric batteries."

- "Where it makes sense to focus on specific verticals, we will. If we find Companies that could benefit by being a part of the SFLM family of companies we will evaluate those.

- "We have an aggressive team and look forward providing more detailed updates in the near future.”

$SFLM CEO Linkedin Profile:

https://www.linkedin.com/in/chad-mackay-2b3417156

Loyal Companies website: https://www.loyalcompanies.com/

"New" $SFLM PRs Since November 15, 2022

Ongoing PR campaign with 1 release to date.

News - November 15. SFLMaven Corp. Announces the Appointment of Chad MacKay as Chairman and CEO and Announces New Business Plan.

https://www.otcmarkets.com/stock/SFLM/news/SF...?id=380331

Share Structure - Updated December 8, 2022

Verified Profile - updated at least monthly.

Authorized Shares: 5,000,000,000 [same as in January 2020]

Outstanding Shares: 2,238,709,801 [no change]

Restricted: 219,001,359 [no change]

Unrestricted: 2,019,708,442 [no change]

Note1: It is only the Unrestricted Outstanding Shares count that is relevant to immediate trading. This is relatively low at 2.02B for a stock in the .0009 > .25 price range.

Note 2: There has now been no change to the Unrestricted Outstanding Shares November 2 > December 11 - 40 days.

Trading Patterns - Previous Business Model - 2021 > November 14, 2022

Note 1: Details of runs in 2019 and 2020 of up to 433% have been deleted - still available to view in the contemporaneous record here.

Note 2: Now that we are expecting runs of 1000% > 2000% in 2022/3 from current levels, details of 8 x runs less than 84% in 2021 have been deleted.

2021

Started breakout from .0038 (previous close) > .0050 on January 6, 2021

Ran from .0052 > .0064 on February 9 - 23%

Ran from .0062 > .0080 on February 10 - 29%

Ran from .0073 > .0091 on February 11 - 25%

Ran from .0070 > .0088 on February 18 - 26%

Ran from .0076 > .0091 on March 3 - 20%

Ran from .0086 (previous close) > .0197 (then new 2021 high) on March 24 - 129%

Ran from .0092 (previous close) > .0169 on March 29 on just under 99M traded - 84%

Ran from .0169 (previous close) > .0200 (new 2021 high) on March 30 - 18%

Ran from .0127 (previous close) > .0160 on April 1 on just 28M traded - 26%

Ran from .0098 (previous close ) > .0119 on April 8 - 21%

Ran from .0060 (previous close) > .0117 on July 15 - 95%

Ran from .0018 (days prior) > .0030 by December 14 - 66%

2022

Ran from .0018 > .0024 on February 4 - 33%

Ran from .0008 > .0014 by March 7+8 - 75%

Ran from .0008 (previous close ask) > .0011 on April 22 - 37.5%

Ran from .0009 (previous close ask) > .0012 on April 27 - 33%

Ran from .0007 (available previously) > .0012 on September 7 - 71%

Ran from .0005 (previous close) > .0007 on September 30 - 40%

Trading Patterns - New Business Model - November 15, 2022 Onwards

Breakout started from .0004 > .0007 on November 15 - 75%

Breakout continued from .0007 > .0010 on November 18 - 43%

Expect a dramatic move up anytime we get sufficiently large buys set across several successive asks - as happened on November 15 and November 18.

We should get past any remaining mass 1-tick flippers by .0012 and be back to a more normal few M per .0001 from .0013 > .0020 then much thinner still after that all the way to the .01>.02+ range IMO.

As with all my long-term top picks, knowing who got what where - relative to you by process of elimination - is important when deciding the ratio of shares to keep long-term vs locking in partial profits at peaks in the .01 > .02+ range - as is patience - this is a long-term play throughout 2022 into 2023.

Performance & Outlook

$SFLM will remain a top profit pick for me throughout 2022 into 2023 for self-evident reasons in this DD.

$SFLM was also my predicted and actual top profit earner in both 2021 and 2020 due to the extent and frequency of its probable short squeeze runs.

It pays to be ready at all times for surges.

Continued large profit trading opportunities are anticipated ahead throughout 2022 and future years for those who maintain a large inventory of shares at a variety of price points. Having plenty of shares - you don't need the cheapest - avoids the need to chase every time it runs.

Cancel any left over ask sell orders at close to get the maximum gap up at each open.

Expect .02+ at some point ahead in 2022/3 as the following catalysts play out:

- Closing of the divestiture transaction of subsidiary SFLMaven of Florida, LLC - along with removal of its losses from the balance sheet and addition of consideration for the sale.

- Clarification whether the Metaverse store is being retained by $SFLM.

- Clarification whether the patent pending "HoloGlow" technology is being retained by $SFLM.

- Updates on the "impressive deal flow of prospects that could be acquired or technology that could be licensed by SFLM” [source: PR November 15, 2022]

- Updates on the lithium mining initiative for batteries.

- Updates on acquisitions.

- Clarification whether uplisting to OTCQB (requiring a sustained .01 bid) or NASDAQ is still planned.

- Possible name change.

- Possible ticker change



SFLMaven, Inc. (SFLM) Stock Research Links

SFLM Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 294

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 637

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 281

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 385

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 254

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
"blog__more"> More News Articles